- Curtiss-Wright recently became technically oversold, with selling pressure easing just as Wall Street analysts revised their earnings estimates higher and showed stronger consensus on the outlook.
- This combination of oversold technicals and upgraded earnings expectations highlights a shift in sentiment that may matter for investors tracking the company’s fundamentals.
- We’ll now explore how the recent analyst earnings upgrades could influence Curtiss-Wright’s existing investment narrative built around defense and nuclear growth.
AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Curtiss-Wright Investment Narrative Recap
To own Curtiss-Wright, you generally need to believe in a durable earnings engine tied to long-cycle defense and nuclear programs, supported by disciplined capital allocation. The recent shift to technically oversold territory, alongside higher analyst earnings estimates, reinforces the existing near term catalyst around execution on its growing backlog rather than creating a new one. The biggest current risk still centers on timing and funding of large defense and nuclear contracts, and this news does not materially change that.
Among recent announcements, the expanded US$2.166 billion share repurchase authorization stands out in light of the stock’s pullback and upgraded earnings estimates. While not altering the core defense and nuclear growth thesis, ongoing buybacks and the higher 2026 earnings guidance frame how management is deploying cash as the business grows, amplifying the impact of any near term sentiment shift if execution on existing orders stays on track.
Yet, against this more constructive short term sentiment shift, investors should still be aware of the concentration risk in long dated defense and nuclear projects...
Read the full narrative on Curtiss-Wright (it's free!)
Curtiss-Wright's narrative projects $4.5 billion revenue and $735.8 million earnings by 2029. This requires 7.7% yearly revenue growth and about a $224.7 million earnings increase from $511.1 million today.
Uncover how Curtiss-Wright's forecasts yield a $814.83 fair value, a 32% upside to its current price.
Exploring Other Perspectives
While consensus treats backlog and contract visibility as the main cushion, the more optimistic analysts see 2029 earnings near US$758 million and margins rising, which could be tested if global policy drift away from traditional nuclear and fossil fuel exposure accelerates.
Explore 5 other fair value estimates on Curtiss-Wright - why the stock might be worth as much as 40% more than the current price!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Curtiss-Wright research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free Curtiss-Wright research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Curtiss-Wright's overall financial health at a glance.
Seeking Other Investments?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Uncover the next big thing with 23 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com